{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:50:27Z","timestamp":1791453027127,"version":"4.3.3"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG073323"],"award-info":[{"award-number":["U01AG073323"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R35AG71476, R25 AG083721-01"],"award-info":[{"award-number":["R35AG71476, R25 AG083721-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG072959"],"award-info":[{"award-number":["P30AG072959"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS133812"],"award-info":[{"award-number":["RF1NS133812"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"DOI":"10.1038\/s41593-026-02472-0","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:02:34Z","timestamp":1791450154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alzheimer\u2019s disease target and drug discovery by leveraging multiomics and electronic health data"],"prefix":"10.1038","author":[{"given":"Yuan","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1355-5018","authenticated-orcid":false,"given":"Yichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Lorincz-Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Gohel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5094-0936","authenticated-orcid":false,"given":"Yunguang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Rivera Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Border","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jena\u2019 N.","family":"Mazique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tousi","family":"Babak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Bekris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0187-5437","authenticated-orcid":false,"given":"Ehud","family":"Karavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2674-0109","authenticated-orcid":false,"given":"Michael","family":"Danziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Rosen-Zvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Leverenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1736-2847","authenticated-orcid":false,"given":"Feixiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2472_CR1","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, E105\u2013E125 (2022)."},{"key":"2472_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/cts.12491","volume":"11","author":"J Cummings","year":"2018","unstructured":"Cummings, J. Lessons learned from Alzheimer disease: clinical trials with negative outcomes. Clin. Transl. Sci. 11, 147\u2013152 (2018).","journal-title":"Clin. Transl. Sci."},{"key":"2472_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2472_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims, J. R. et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330, 512\u2013527 (2023).","journal-title":"JAMA"},{"key":"2472_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims, R., Hill, M. & Williams, J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat. Neurosci. 23, 311\u2013322 (2020).","journal-title":"Nat. Neurosci."},{"key":"2472_CR6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856\u2013860 (2015).","journal-title":"Nat. Genet."},{"key":"2472_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-018-0223-3","volume":"25","author":"V Swarup","year":"2019","unstructured":"Swarup, V. et al. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nat. Med. 25, 152\u2013164 (2019).","journal-title":"Nat. Med."},{"key":"2472_CR8","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000194","volume":"3","author":"GW Beecham","year":"2017","unstructured":"Beecham, G. W. et al. The Alzheimer\u2019s Disease Sequencing Project: study design and sample selection. Neurol. Genet. 3, e194 (2017).","journal-title":"Neurol. Genet."},{"key":"2472_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen, R. C. et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74, 201\u2013209 (2010).","journal-title":"Neurology"},{"key":"2472_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","volume":"611","author":"A Mishra","year":"2022","unstructured":"Mishra, A. et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature 611, 115\u2013123 (2022).","journal-title":"Nature"},{"key":"2472_CR11","volume":"12","author":"R Tonegawa-Kuji","year":"2026","unstructured":"Tonegawa-Kuji, R. et al. Critical evaluation of real-world evidence of repurposable medicines in the Alzheimer\u2019s disease drug development pipeline using a target trial emulation. Alzheimers Dement. 12, e70193 (2026).","journal-title":"Alzheimers Dement."},{"key":"2472_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s43587-021-00138-z","volume":"1","author":"J Fang","year":"2021","unstructured":"Fang, J. et al. Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer\u2019s disease. Nat. Aging 1, 1175\u20131188 (2021).","journal-title":"Nat. Aging"},{"key":"2472_CR13","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/alz.12819","volume":"19","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer\u2019s disease in African Americans. Alzheimers Dement. 19, 1876\u20131887 (2023).","journal-title":"Alzheimers Dement."},{"key":"2472_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ajhg.2021.01.012","volume":"108","author":"C Robins","year":"2021","unstructured":"Robins, C. et al. Genetic control of the human brain proteome. Am. J. Hum. Genet. 108, 400\u2013410 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"2472_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41588-023-01300-6","volume":"55","author":"N de Klein","year":"2023","unstructured":"de Klein, N. et al. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat. Genet. 55, 377\u2013388 (2023).","journal-title":"Nat. Genet."},{"key":"2472_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.89","volume":"3","author":"M Allen","year":"2016","unstructured":"Allen, M. et al. Human whole genome genotype and transcriptome data for Alzheimer\u2019s and other neurodegenerative diseases. Scientific Data 3, 160089 (2016).","journal-title":"Scientific Data"},{"key":"2472_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14156-4","volume":"11","author":"S Burgess","year":"2020","unstructured":"Burgess, S., Foley, C. N., Allara, E., Staley, J. R. & Howson, J. M. M. A robust and efficient method for Mendelian randomization with hundreds of genetic variants. Nat. Commun. 11, 376 (2020).","journal-title":"Nat. Commun."},{"key":"2472_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"2472_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41588-019-0367-1","volume":"51","author":"N Mancuso","year":"2019","unstructured":"Mancuso, N. et al. Probabilistic fine-mapping of transcriptome-wide association studies. Nat. Genet. 51, 675\u2013682 (2019).","journal-title":"Nat. Genet."},{"key":"2472_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"2472_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"2472_CR22","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41588-022-01149-1","volume":"54","author":"R Kosoy","year":"2022","unstructured":"Kosoy, R. et al. Genetics of the human microglia regulome refines Alzheimer\u2019s disease risk loci. Nat. Genet. 54, 1145\u20131154 (2022).","journal-title":"Nat. Genet."},{"key":"2472_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jamaneurol.2020.3536","volume":"78","author":"BW Kunkle","year":"2021","unstructured":"Kunkle, B. W. et al. Novel Alzheimer disease risk loci and pathways in African American individuals using the African Genome Resources panel: a meta-analysis. JAMA Neurol. 78, 102\u2013113 (2021).","journal-title":"JAMA Neurol."},{"key":"2472_CR24","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement. 9, e12385 (2023).","journal-title":"Alzheimers Dement."},{"key":"2472_CR25","volume":"7","author":"J Cummings","year":"2021","unstructured":"Cummings, J., Lee, G., Zhong, K., Fonseca, J. & Taghva, K. Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimers Dement. 7, e12179 (2021).","journal-title":"Alzheimers Dement."},{"key":"2472_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38676-7","volume":"9","author":"YJ Chen","year":"2019","unstructured":"Chen, Y. J. et al. Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation. Sci. Rep. 9, 2516 (2019).","journal-title":"Sci. Rep."},{"key":"2472_CR27","doi-asserted-by":"publisher","first-page":"16743","DOI":"10.1073\/pnas.1208011109","volume":"109","author":"L Wang","year":"2012","unstructured":"Wang, L. et al. Epidermal growth factor receptor is a preferred target for treating amyloid-\u03b2-induced memory loss. Proc. Natl Acad. Sci. USA 109, 16743\u201316748 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2472_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13332","volume":"20","author":"HJ Lee","year":"2021","unstructured":"Lee, H. J. et al. Ibrutinib modulates A\u03b2\/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer\u2019s disease. Aging Cell 20, e13332 (2021).","journal-title":"Aging Cell"},{"key":"2472_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb1206","volume":"12","author":"A Ghosh","year":"2020","unstructured":"Ghosh, A. et al. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease. Sci. Transl. Med. 12, eabb1206 (2020).","journal-title":"Sci. Transl. Med."},{"key":"2472_CR30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s41588-020-00721-x","volume":"52","author":"MR Corces","year":"2020","unstructured":"Corces, M. R. et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer\u2019s and Parkinson\u2019s diseases. Nat. Genet. 52, 1158\u20131168 (2020).","journal-title":"Nat. Genet."},{"key":"2472_CR31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","volume":"185","author":"TE Tracy","year":"2022","unstructured":"Tracy, T. E. et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell 185, 712\u2013728 (2022).","journal-title":"Cell"},{"key":"2472_CR32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-022-02454-z","volume":"144","author":"IE Jansen","year":"2022","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis for Alzheimer\u2019s disease cerebrospinal fluid biomarkers. Acta Neuropathol. 144, 821\u2013842 (2022).","journal-title":"Acta Neuropathol."},{"key":"2472_CR33","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","volume":"17","author":"JL Doman","year":"2022","unstructured":"Doman, J. L., Sousa, A. A., Randolph, P. B., Chen, P. J. & Liu, D. R. Designing and executing prime editing experiments in mammalian cells. Nat. Protoc. 17, 2431\u20132468 (2022).","journal-title":"Nat. Protoc."},{"key":"2472_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13195-021-00893-6","volume":"13","author":"K Borkowski","year":"2021","unstructured":"Borkowski, K. et al. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer\u2019s disease. Alzheimers Res. Ther. 13, 149 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"2472_CR35","doi-asserted-by":"publisher","unstructured":"Elsworth, B. et al. The MRC IEU OpenGWAS data infrastructure. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.08.10.244293 (2020).","DOI":"10.1101\/2020.08.10.244293"},{"key":"2472_CR36","doi-asserted-by":"publisher","unstructured":"Mitchell, R. C. et al. MRC IEU UK Biobank GWAS pipeline version 2. Univ. Bristol Research Data Repository https:\/\/doi.org\/10.5523\/bris.2fahpksont1zi26xosyamqo8rr (2019).","DOI":"10.5523\/bris.2fahpksont1zi26xosyamqo8rr"},{"key":"2472_CR37","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/alz.12509","volume":"18","author":"JC Lennon","year":"2022","unstructured":"Lennon, J. C. et al. Black and white individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement. 18, 1461\u20131471 (2022).","journal-title":"Alzheimers Dement."},{"key":"2472_CR38","first-page":"57","volume":"3","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y. et al. African Americans are less likely to enroll in preclinical Alzheimer\u2019s disease clinical trials. Alzheimers Dement. 3, 57\u201364 (2017).","journal-title":"Alzheimers Dement."},{"key":"2472_CR39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian, M. et al. PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557\u2013566 (2013).","journal-title":"Nat. Med."},{"key":"2472_CR40","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.jalz.2018.03.008","volume":"14","author":"HC Hendrie","year":"2018","unstructured":"Hendrie, H. C. et al. Changes of glucose levels precede dementia in African-Americans with diabetes but not in Caucasians. Alzheimers Dement. 14, 1572\u20131579 (2018).","journal-title":"Alzheimers Dement."},{"key":"2472_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/bio.2015.29031.hmm","volume":"13","author":"LJ Carithers","year":"2015","unstructured":"Carithers, L. J. & Moore, H. M. The Genotype-Tissue Expression (GTEx) Project. Biopreserv. Biobank 13, 307\u2013308 (2015).","journal-title":"Biopreserv. Biobank"},{"key":"2472_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30537-8","volume":"13","author":"A Neuberger","year":"2022","unstructured":"Neuberger, A., Nadezhdin, K. D. & Sobolevsky, A. I. Structural mechanism of TRPV3 channel inhibition by the anesthetic dyclonine. Nat. Commun. 13, 2795 (2022).","journal-title":"Nat. Commun."},{"key":"2472_CR43","doi-asserted-by":"publisher","first-page":"100931","DOI":"10.1016\/j.isci.2020.100931","volume":"23","author":"BH Varkuti","year":"2020","unstructured":"Varkuti, B. H. et al. High-throughput small molecule screen identifies modulators of mitochondrial function in neurons. iScience 23, 100931 (2020).","journal-title":"iScience"},{"key":"2472_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack, C. R. Jr et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"2472_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ebiom.2018.10.001","volume":"37","author":"MK Kwok","year":"2018","unstructured":"Kwok, M. K., Lin, S. L. & Schooling, C. M. Re-thinking Alzheimer\u2019s disease therapeutic targets using gene-based tests. EBioMedicine 37, 461\u2013470 (2018).","journal-title":"EBioMedicine"},{"key":"2472_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","volume":"53","author":"C Morisseau","year":"2013","unstructured":"Morisseau, C. & Hammock, B. D. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu. Rev. Pharmacol. Toxicol. 53, 37\u201358 (2013).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2472_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00830-3","volume":"18","author":"B He","year":"2020","unstructured":"He, B., Shi, J., Wang, X., Jiang, H. & Zhu, H. J. Genome-wide pQTL analysis of protein expression regulatory networks in the human liver. BMC Biol. 18, 97 (2020).","journal-title":"BMC Biol."},{"key":"2472_CR48","unstructured":"GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020)."},{"key":"2472_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24219-z","volume":"8","author":"T Strunz","year":"2018","unstructured":"Strunz, T. et al. A mega-analysis of expression quantitative trait loci (eQTL) provides insight into the regulatory architecture of gene expression variation in liver. Sci. Rep. 8, 5865 (2018).","journal-title":"Sci. Rep."},{"key":"2472_CR50","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","volume":"111","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Hepatic soluble epoxide hydrolase activity regulates cerebral A\u03b2 metabolism and the pathogenesis of Alzheimer\u2019s disease in mice. Neuron 111, 2847\u20132862 (2023).","journal-title":"Neuron"},{"key":"2472_CR51","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","volume":"23","author":"J Camacho-Pereira","year":"2016","unstructured":"Camacho-Pereira, J. et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 23, 1127\u20131139 (2016).","journal-title":"Cell Metab."},{"key":"2472_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2672","volume":"4","author":"P Verheugd","year":"2013","unstructured":"Verheugd, P. et al. Regulation of NF-\u03baB signalling by the mono-ADP-ribosyltransferase ARTD10. Nat. Commun. 4, 1683 (2013).","journal-title":"Nat. Commun."},{"key":"2472_CR53","volume":"9","author":"S Bathla","year":"2023","unstructured":"Bathla, S. et al. Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques. Alzheimers Dement. 9, e12431 (2023).","journal-title":"Alzheimers Dement."},{"key":"2472_CR54","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1182\/blood.2020008951","volume":"137","author":"CB Keragala","year":"2021","unstructured":"Keragala, C. B. & Medcalf, R. L. Plasminogen: an enigmatic zymogen. Blood 137, 2881\u20132889 (2021).","journal-title":"Blood"},{"key":"2472_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ebiom.2017.02.017","volume":"17","author":"I Rajman","year":"2017","unstructured":"Rajman, I., Knapp, L., Morgan, T. & Masimirembwa, C. African genetic diversity: implications for cytochrome P450-mediated drug metabolism and drug development. EBioMedicine 17, 67\u201374 (2017).","journal-title":"EBioMedicine"},{"key":"2472_CR56","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/01621459.2018.1554485","volume":"115","author":"Y Liu","year":"2020","unstructured":"Liu, Y. & Xie, J. Cauchy combination test: a powerful test with analytic p-value calculation under arbitrary dependency structures. J. Am. Stat. Assoc. 115, 393\u2013402 (2020).","journal-title":"J. Am. Stat. Assoc."},{"key":"2472_CR57","doi-asserted-by":"publisher","first-page":"e1004568","DOI":"10.1371\/journal.pmed.1004568","volume":"22","author":"R Tonegawa-Kuji","year":"2025","unstructured":"Tonegawa-Kuji, R. et al. Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer\u2019s disease: a systematic review and meta-analysis. PLoS Med. 22, e1004568 (2025).","journal-title":"PLoS Med."},{"key":"2472_CR58","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/s41591-025-03835-z","volume":"31","author":"A Shvetcov","year":"2025","unstructured":"Shvetcov, A. et al. APOE \u03b54 carriers share immune-related proteomic changes across neurodegenerative diseases. Nat. Med. 31, 2590\u20132601 (2025).","journal-title":"Nat. Med."},{"key":"2472_CR59","unstructured":"The All of Us Research Program Genomics Investigators. Genomic data in the All of Us Research Program. Nature 627, 340\u2013346 (2024)."},{"key":"2472_CR60","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat. Genet. 53, 1276\u20131282 (2021).","journal-title":"Nat. Genet."},{"key":"2472_CR61","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber, J. et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat. Genet. 53, 392\u2013402 (2021).","journal-title":"Nat. Genet."},{"key":"2472_CR62","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"2472_CR63","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson, M. K. et al. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44, D1045\u2013D1053 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2472_CR64","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton, A. et al. The ChEMBL database in 2017. Nucleic Acids Res. 45, D945\u2013D954 (2017).","journal-title":"Nucleic Acids Res."},{"key":"2472_CR65","doi-asserted-by":"publisher","first-page":"D1282","DOI":"10.1093\/nar\/gkab1010","volume":"50","author":"SD Harding","year":"2022","unstructured":"Harding, S. D. et al. The IUPHAR\/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials. Nucleic Acids Res. 50, D1282\u2013D1294 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2472_CR66","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2472_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-020-00642-8","volume":"7","author":"SK Sieberts","year":"2020","unstructured":"Sieberts, S. K. et al. Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions. Scientific Data 7, 340 (2020).","journal-title":"Scientific Data"},{"key":"2472_CR68","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41588-023-01300-6","volume":"55","author":"N de Klein","year":"2023","unstructured":"de Klein, N. et al. Brain expression quantitative trait locus and network analysis reveals downstream effects and putative drivers for brain-related diseases. Nat. Genet. 55, 377\u2013388 (2023).","journal-title":"Nat. Genet."},{"key":"2472_CR69","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett, D. A., Schneider, J. A., Arvanitakis, Z. & Wilson, R. S. Overview and findings from the religious orders study. Curr. Alzheimer Res. 9, 628\u2013645 (2012).","journal-title":"Curr. Alzheimer Res."},{"key":"2472_CR70","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2174\/156720512801322663","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett, D. A. et al. Overview and findings from the rush Memory and Aging Project. Curr. Alzheimer Res. 9, 646\u2013663 (2012).","journal-title":"Curr. Alzheimer Res."},{"key":"2472_CR71","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/nn.4632","volume":"20","author":"B Ng","year":"2017","unstructured":"Ng, B. et al. An xQTL map integrates the genetic architecture of the human brain\u2019s transcriptome and epigenome. Nat. Neurosci. 20, 1418\u20131426 (2017).","journal-title":"Nat. Neurosci."},{"key":"2472_CR72","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41588-021-00976-y","volume":"54","author":"KP Lopes","year":"2022","unstructured":"Lopes, K. P. et al. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Nat. Genet. 54, 4\u201317 (2022).","journal-title":"Nat. Genet."},{"key":"2472_CR73","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41593-022-01128-z","volume":"25","author":"J Bryois","year":"2022","unstructured":"Bryois, J. et al. Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders. Nat. Neurosci. 25, 1104\u20131112 (2022).","journal-title":"Nat. Neurosci."},{"key":"2472_CR74","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41588-024-01685-y","volume":"56","author":"M Fujita","year":"2024","unstructured":"Fujita, M. et al. Cell subtype-specific effects of genetic variation in the Alzheimer\u2019s disease brain. Nat. Genet. 56, 605\u2013614 (2024).","journal-title":"Nat. Genet."},{"key":"2472_CR75","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89\u2013R98 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"2472_CR76","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","volume":"27","author":"L Gaziano","year":"2021","unstructured":"Gaziano, L. et al. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat. Med. 27, 668\u2013676 (2021).","journal-title":"Nat. Med."},{"key":"2472_CR77","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber, V. et al. Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches. Am. J. Hum. Genet. 109, 767\u2013782 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"2472_CR78","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Primers 2, 6 (2022).","journal-title":"Nat. Rev. Methods Primers"},{"key":"2472_CR79","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"2472_CR80","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Small, D. S. & Thompson, S. G. A review of instrumental variable estimators for Mendelian randomization. Stat. Methods Med. Res. 26, 2333\u20132355 (2017).","journal-title":"Stat. Methods Med. Res."},{"key":"2472_CR81","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska, O. O. & Burgess, S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int. J. Epidemiol. 46, 1734\u20131739 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"2472_CR82","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).","journal-title":"PLoS Genet."},{"key":"2472_CR83","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ng.2213","volume":"44","author":"J Yang","year":"2012","unstructured":"Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369\u2013375 (2012).","journal-title":"Nat. Genet."},{"key":"2472_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"D Ho","year":"2011","unstructured":"Ho, D., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Softw. 42, 1\u201328 (2011).","journal-title":"J. Stat. Softw."},{"key":"2472_CR85","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1198\/106186006X137047","volume":"15","author":"BB Hansen","year":"2006","unstructured":"Hansen, B. B. & Klopfer, S. O. Optimal full matching and related designs via network flows. J. Comput. Graphical Stat. 15, 609\u2013627 (2006).","journal-title":"J. Comput. Graphical Stat."},{"key":"2472_CR86","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JAD-231391","volume":"98","author":"D Gohel","year":"2024","unstructured":"Gohel, D. et al. Sildenafil as a candidate drug for Alzheimer\u2019s disease: real-world patient data observation and mechanistic observations from patient-induced pluripotent stem cell-derived neurons. J. Alzheimers Dis. 98, 643\u2013657 (2024).","journal-title":"J. Alzheimers Dis."},{"key":"2472_CR87","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.stem.2014.05.018","volume":"15","author":"F Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez, F. et al. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. Cell Stem Cell 15, 215\u2013226 (2014).","journal-title":"Cell Stem Cell"},{"key":"2472_CR88","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02472-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02472-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02472-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:02:37Z","timestamp":1791450157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02472-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":88,"alternative-id":["2472"],"URL":"https:\/\/doi.org\/10.1038\/s41593-026-02472-0","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"17 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C. has provided consultation to AB Science, Acadia, Alkahest, AlphaCognition, ALZPath, Annovis, AriBio, Artery, Avanir, Biogen, Biosplice, Cassava, Cerevel, Clinilabs, Cortexyme, Diadem, EIP Pharma, Eisai, GatehouseBio, GemVax, Genentech, Green Valley, Grifols, Janssen, Karuna, Lexeo, Lilly, Lundbeck, LSP, Merck, NervGen, Novo Nordisk, Oligomerix, Ono, Otsuka, PharmacotrophiX, PRODEO, Prothena, ReMYND, Renew, Resverlogix, Roche, Signant Health, Suven, Unlearn AI, Vaxxinity, Vigil Neuro pharmaceutical, assessment and investment companies. J.B.L. has received consulting fees from Vaxxinity and grant support from GE HealthCare. He serves on a Data Safety Monitoring Board for Eisai. B.D.H. is a cofounder and CEO of EicOsis LLC. S.H.H. is a part-time employee of EicOsis LLC. H.Z. serves on the Scientific Advisory Board of the Tau Consortium, which is managed by the Rainwater Charitable Foundation. E.K., M.D. and M.R.Z. are employees of the IBM Research. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}